Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BPMC | IBRX | HALO | ||
| Company | Blueprint Medicines Corp | Immunitybio Inc | Halozyme Therapeutic | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 129.35 | 8.37 | 69.57 | ||
| High | 129.55 | 8.56 | 70.02 | ||
| Low | 129.30 | 7.98 | 68.24 | ||
| Latest | 129.46 | 8.10 | 68.41 | ||
| Change | +0.18 | -0.10 | -1.16 | ||
| % Change | +0.14% | -1.22% | -1.67% | ||
| Volume | 2,980,900 | 13,170,200 | 1,542,600 | ||
| 20-Day Average Volume | 4,470,280 | 21,167,545 | 1,333,680 | ||
| Previous Close | 129.28 | 8.20 | 69.57 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 128.60 | 7.43 | 65.51 | ||
| 20-Day Raw Stochastic | 88.49% | 59.77% | 78.85% | ||
| 20-Day Relative Strength | 73.17 | 53.37 | 53.26 | ||
| Weighted Alpha | +17.08 | +25.61 | +12.66 | ||
| Today's Opinion | 100% Buy | 72% Buy | 8% Sell | ||
| Previous Opinion | 100% Buy | 72% Buy | 24% Buy | ||
| Last Month's Opinion | 100% Buy | 80% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 07/10/25 | +6.58% since 04/14/26 | +1.63% since 04/14/26 | ||
| Low | 129.00 on 07/11/25 | 7.12 on 04/16/26 | 66.36 on 04/16/26 | ||
| High | 129.65 on 07/16/25 | 8.56 on 04/21/26 | 70.31 on 04/20/26 | ||
| 1-Month | |||||
| %Chg | +0.96% since 06/17/25 | -4.37% since 03/20/26 | +7.85% since 03/20/26 | ||
| Low | 128.00 on 06/20/25 | 6.54 on 03/24/26 | 61.33 on 03/27/26 | ||
| High | 129.65 on 07/16/25 | 9.54 on 03/23/26 | 70.31 on 04/20/26 | ||
| 3-Month | |||||
| %Chg | +52.86% since 04/17/25 | +17.05% since 01/21/26 | -4.60% since 01/21/26 | ||
| Low | 83.27 on 04/22/25 | 5.54 on 01/28/26 | 61.33 on 03/27/26 | ||
| High | 129.65 on 07/16/25 | 12.43 on 02/25/26 | 82.22 on 02/09/26 | ||
| 6-Month | |||||
| %Chg | +17.64% since 01/17/25 | +231.97% since 10/21/25 | +2.29% since 10/21/25 | ||
| Low | 73.04 on 04/09/25 | 1.95 on 12/31/25 | 61.22 on 12/11/25 | ||
| High | 129.65 on 07/16/25 | 12.43 on 02/25/26 | 82.22 on 02/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,360,786 | 8,430,510 | 8,242,236 | ||
| Shares Outstanding, K | 64,582 | 1,028,111 | 118,474 | ||
| Annual Sales | 508,820,000 | 113,290,000 | 1,396,610,000 | ||
| Annual Net Income | -67,090,000 | -351,400,000 | 316,890,000 | ||
| Last Quarter Sales | 149,410,000 | 38,290,000 | 451,770,000 | ||
| Last Quarter Net Income | 500,000 | -61,940,000 | -141,590,000 | ||
| 60-Month Beta | 0.89 | 0.13 | 1.03 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.74 on 05/01/25 | -0.06 on 02/23/26 | -0.24 on 02/17/26 | ||
| Latest Earnings Date | 08/07/25 | 05/11/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 18.33 | ||